Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectations The drug, Aduhelm, brought in $300,000 in revenue in its [...] By digitalstudios|2021-10-20T20:06:11+00:00October 20, 2021|3rd Party Pharmaceutical Industry News|Comments Off on Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectations Read More
